Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study
Qi Tan, Yang Jin
doi: https://doi.org/10.1101/2020.05.15.20102392
Qi Tan
1Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Disease
MDYang Jin
2Wuhan Union Hospital
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
Posted May 20, 2020.
Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study
Qi Tan, Yang Jin
medRxiv 2020.05.15.20102392; doi: https://doi.org/10.1101/2020.05.15.20102392
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (659)
- Anesthesia (177)
- Cardiovascular Medicine (2577)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12100)
- Forensic Medicine (10)
- Gastroenterology (747)
- Genetic and Genomic Medicine (4006)
- Geriatric Medicine (376)
- Health Economics (669)
- Health Informatics (2585)
- Health Policy (993)
- Hematology (357)
- HIV/AIDS (826)
- Medical Education (396)
- Medical Ethics (107)
- Nephrology (424)
- Neurology (3773)
- Nursing (207)
- Nutrition (560)
- Oncology (1966)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1092)
- Primary Care Research (442)
- Public and Global Health (6440)
- Radiology and Imaging (1370)
- Respiratory Medicine (862)
- Rheumatology (394)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (164)